A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease.
Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results